In their fruit-fly experiments, researchers at the University of Michigan, led by Thomas J. Waller and Monica Dus, watched how changes in sugar use affected a neuron’s ability to bounce back after injury.
They discovered that quick bursts of healthy metabolism can switch on a short-term protective response, slowing down cell damage through signals involving DLK and SARM1. This protective window showed up consistently across many neurons, but it lasted only as long as the cell’s sugar processing remained stable and favorable.
The Dual-Life of DLK
DLK’s role is a double-edged sword: early activation supports a protective transcriptional response, preserving axons, but when DLK remains active for too long, degeneration accelerates via SARM1’s downstream reach. This suggests the brain harbors a metabolic switch that can be tuned by dietary or pharmacological means. For context, ScienceDaily summarizes the discovery: ScienceDaily. The mechanism is further tied to metabolic signaling pathways discussed in Molecular Metabolism.
From Lab to Therapy
If metabolism can toggle resilience, therapies could be designed to sustain the protective state without triggering DLK-driven degeneration. Potential avenues include metabolic interventions that normalize glucose flux and targeted modulation of DLK/SARM1 signaling to extend the protective window while avoiding harm.
The era of one-size-fits-all neurodrugs is ending; the future belongs to metabolic tuning of the brain’s own protective switch.
Related Reading
New research explores how the brain sometimes mixes up internal thoughts with external sounds, helping debunk myths about hearing voices in schizophrenia.
Read the Full Story